<VariationArchive RecordType="classified" VariationID="15900" VariationName="NC_000016.10:g.(?_72054504)_(?_72076977)del" VariationType="Deletion" Accession="VCV000015900" Version="1" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2023-08-26" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="30939" VariationID="15900">
      <GeneList>
        <Gene Symbol="HP" FullName="haptoglobin" GeneID="3240" HGNC_ID="HGNC:5141" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="72054505" stop="72061055" display_start="72054505" display_stop="72061055" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="72088507" stop="72094954" display_start="72088507" display_stop="72094954" Strand="+" />
          </Location>
          <OMIM>140100</OMIM>
        </Gene>
        <Gene Symbol="HPR" FullName="haptoglobin-related protein" GeneID="3250" HGNC_ID="HGNC:5156" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>16q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="72063226" stop="72077246" display_start="72063226" display_stop="72077246" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="72097124" stop="72111144" display_start="72097124" display_stop="72111144" Strand="+" />
          </Location>
          <OMIM>140210</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000016.10:g.(?_72054504)_(?_72076977)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" innerStart="72054504" outerStop="72076977" display_start="72054504" display_stop="72076977" variantLength="22474" />
      </Location>
      <OtherNameList>
        <Name>HP, DEL</Name>
        <Name>DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.(?_72054504)_(?_72076977)del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.(?_72054504)_(?_72076977)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="140100.0003" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 40100.0003 to represent a deletion including the 5' end of HP with an outer boundary at the 3' end at the BamHI site in exon 5 of HPR.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.10:g.(?_72054504)_(?_72076977)del AND Anhaptoglobinemia" Accession="RCV000017246" Version="25">
        <ClassifiedConditionList TraitSetID="5166">
          <ClassifiedCondition DB="MedGen" ID="C3279786">Anhaptoglobinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-11-01" SubmissionCount="1">Affects</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000016.10:g.(?_72054504)_(?_72076977)del AND Hypohaptoglobinemia" Accession="RCV000017247" Version="27">
        <ClassifiedConditionList TraitSetID="5167">
          <ClassifiedCondition DB="MedGen" ID="C3279787">Hypohaptoglobinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2003-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2003-11-01" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic; Affects</Description>
        <Citation Type="general">
          <ID Source="PubMed">10644822</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10666182</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14616769</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9463309</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-18">
          <Description>Pathogenic, Affects</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="5166" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12438" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ANHAPTOGLOBINEMIA, SUSCEPTIBILITY TO</ElementValue>
                <XRef Type="Allelic variant" ID="140100.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="140100.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AHAPTOGLOBINEMIA</ElementValue>
                <XRef Type="MIM" ID="614081" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anhaptoglobinemia</ElementValue>
                <XRef ID="20039" DB="GeneTests" />
                <XRef ID="Anhaptoglobinemia/7694" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013564" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AHP</ElementValue>
                <XRef Type="MIM" ID="614081" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Anhaptoglobinemia refers to absence of the serum glycoprotein haptoglobin, a hemoglobin-binding acute-phase protein (summary by Teye et al., 2004). Serum levels of haptoglobin vary among normal persons: levels are low in the neonatal period and in the elderly, differ by population, and can be influenced by environmental factors, such as infection. Secondary hypohaptoglobinemia can occur as a consequence of hemolysis, during which haptoglobin binds to free hemoglobin (summary by Delanghe et al., 1998).</Attribute>
                <XRef Type="MIM" ID="614081" DB="OMIM" />
              </AttributeSet>
              <XRef ID="C3279786" DB="MedGen" />
              <XRef ID="MONDO:0013564" DB="MONDO" />
              <XRef Type="MIM" ID="614081" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5167" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12439" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypohaptoglobinemia</ElementValue>
              </Name>
              <XRef ID="C3279787" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37518" SubmissionDate="2012-11-02" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="140100.0003_ANHAPTOGLOBINEMIA" title="HP, DEL_ANHAPTOGLOBINEMIA" />
        <ClinVarAccession Accession="SCV000037518" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Affects</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Japanese person with anhaptoglobinemia (614081), Koda et al. (1998) found homozygosity for deletion of a segment of chromosome 16 extending from at least the promoter region of HP to HPR-alpha but not to HPR-beta. In addition, they found 7 persons with hypohaptoglobinemia (see 614081) in 3 families, and the genotype of 6 of the 7 individuals was found to be HP2/HP-del. The HP2/HP-del individuals with hypohaptoglobinemia had an extremely low level of haptoglobin, compared with the level obtained in 52 healthy volunteers with phenotype HP2, whereas the serum haptoglobin level of an individual with HP1/HP-del was 0.50 mg/ml, which was approximately half the level of haptoglobin in control sera from the HP1 phenotype, showing a gene-dosage effect. By DNA sequencing of all exons, the other allele (HP2) of individuals with HP2/HP-del was found to have no mutations. Hypohaptoglobinemia and anhaptoglobinemia have no clear pathologic consequences.</Attribute>
              <Citation>
                <ID Source="PubMed">9463309</ID>
              </Citation>
              <XRef DB="OMIM" ID="614081" Type="MIM" />
              <XRef DB="OMIM" ID="614081" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Anhaptoglobinemia due to homozygous deletion of a segment measuring approximately 28 kb on chromosome 16 and extending from the promoter region of the HP gene to exon 5 of the haptoglobin-related gene (HPR; 140210) had been found in Japan, Korea, and China but not elsewhere. In these countries, anhaptoglobinemia has important clinical consequences; it is responsible for anaphylactic reactions in blood transfusions (Koda et al., 2000; Morishita et al., 2000). Teye et al. (2003) found that the so-called Hp0 anhaptoglobinemia phenotype in Ghana (West Africa) (see 140100.0004) has a different genetic basis than that seen in Asia.</Attribute>
              <Citation>
                <ID Source="PubMed">10666182</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10644822</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">14616769</ID>
              </Citation>
              <XRef DB="OMIM" ID="140210" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HP" />
          </GeneList>
          <Name>HP, DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="140100.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANHAPTOGLOBINEMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="37519" SubmissionDate="2012-11-02" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="140100.0003_HYPOHAPTOGLOBINEMIA" title="HP, DEL_HYPOHAPTOGLOBINEMIA" />
        <ClinVarAccession Accession="SCV000037519" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Japanese person with anhaptoglobinemia (614081), Koda et al. (1998) found homozygosity for deletion of a segment of chromosome 16 extending from at least the promoter region of HP to HPR-alpha but not to HPR-beta. In addition, they found 7 persons with hypohaptoglobinemia (see 614081) in 3 families, and the genotype of 6 of the 7 individuals was found to be HP2/HP-del. The HP2/HP-del individuals with hypohaptoglobinemia had an extremely low level of haptoglobin, compared with the level obtained in 52 healthy volunteers with phenotype HP2, whereas the serum haptoglobin level of an individual with HP1/HP-del was 0.50 mg/ml, which was approximately half the level of haptoglobin in control sera from the HP1 phenotype, showing a gene-dosage effect. By DNA sequencing of all exons, the other allele (HP2) of individuals with HP2/HP-del was found to have no mutations. Hypohaptoglobinemia and anhaptoglobinemia have no clear pathologic consequences.</Attribute>
              <Citation>
                <ID Source="PubMed">9463309</ID>
              </Citation>
              <XRef DB="OMIM" ID="614081" Type="MIM" />
              <XRef DB="OMIM" ID="614081" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Anhaptoglobinemia due to homozygous deletion of a segment measuring approximately 28 kb on chromosome 16 and extending from the promoter region of the HP gene to exon 5 of the haptoglobin-related gene (HPR; 140210) had been found in Japan, Korea, and China but not elsewhere. In these countries, anhaptoglobinemia has important clinical consequences; it is responsible for anaphylactic reactions in blood transfusions (Koda et al., 2000; Morishita et al., 2000). Teye et al. (2003) found that the so-called Hp0 anhaptoglobinemia phenotype in Ghana (West Africa) (see 140100.0004) has a different genetic basis than that seen in Asia.</Attribute>
              <Citation>
                <ID Source="PubMed">10666182</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10644822</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">14616769</ID>
              </Citation>
              <XRef DB="OMIM" ID="140210" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HP" />
          </GeneList>
          <Name>HP, DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="140100.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">HYPOHAPTOGLOBINEMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37519" TraitType="Disease" MappingType="Name" MappingValue="HYPOHAPTOGLOBINEMIA" MappingRef="Alternate">
        <MedGen CUI="C3279787" Name="Hypohaptoglobinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="37518" TraitType="Disease" MappingType="Name" MappingValue="ANHAPTOGLOBINEMIA" MappingRef="Preferred">
        <MedGen CUI="C3279786" Name="Anhaptoglobinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

